Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Grifols SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Grifols SA, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Grifols SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Grifols SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Grifols SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Grifols SA, Medical Equipment, Deal Details 11
Asset Purchase 11
Grifols Acquires Nucleic Acid Testing Donor Screening Unit from Hologic for USD1.85 Billion 11
Grifols Acquires Blood Transfusion Diagnostics Business from Novartis for USD1.66 Billion 13
Partnerships 15
Singulex Enters into Licensing Agreement with Grifols 15
Grifols and Beckman Coulter Enter into Distribution Agreement 16
Grifols Enters Into Distribution Agreement With Kainos Labs 17
Health Robotics Enters Into Co-Marketing Agreement With Grifols 18
Grifols Enters Into Co-Marketing Agreement With Novartis 19
Grifols Enters Into Licensing Agreement With Aradigm 20
Equity Offering 21
Grifols Invests USD50 Million in Singulex 21
TiGenix Completes Private Placement Of Shares For US$16.2 Million 22
Debt Offering 23
Grifols Raises USD1.06 Billion in Public Offering of 3.2% Bonds Due 2025 23
Grifols Completes Public Offering Of Bonds Due 2022 For US$1 Billion 24
Acquisition 25
Grifols Acquires Additional 40% Stake in Kiro Grifols for USD15 Million 25
Grifols Acquires Additional 32.93% Stake in Progenika Biopharma for USD27 Million 26
Grifols Acquires 50% Stake in Kiro Robotics for USD27 Million 27
Alken Asset Management Sells 2.72% Stake In Grifols For US$227 Million 28
Grifols Completes Acquisition Of 35% Stake In Aradigm For US$26 Million 29
Grifols Acquires 60% Stake In Progenika Biopharma For US$48 Million 30
Grifols Acquires Remaining 51% Stake In Lateral-Medion 31
Grifols SA – Key Competitors 32
Grifols SA – Key Employees 33
Grifols SA – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 38
Financial Announcements 38
Nov 02, 2017: Grifols increases its revenues by 10% to Euros 3,250 million and grows net profit by 6.3% to reach Euros 432 million 38
Jul 28, 2017: Grifols increases its revenues by 12.3% to EUR 2,192 million driven by growth of its main divisions 42
May 03, 2017: Bioscience Division sales increase 15% to drive Grifols’ revenue growth by 11% to Euros 1,062 million 48
Feb 28, 2017: Grifols’ revenues exceed Euros 4,000 million, driven by +6.5% growth of the Bioscience Division 52
Nov 08, 2016: Sales of the Bioscience Division grow by +6.5%, increasing Grifols’ revenues to EUR 2,952 million 60
Jul 28, 2016: Sales of the Bioscience Division grow by +7.0%, increasing Grifols’ revenues by +2.7% to EUR 1,952 million 64
May 05, 2016: Grifols’ revenues increase by +5.6% to Euros 959 million, driven by growth of +10.9% for the Bioscience Division 70
Feb 29, 2016: Grifols’ revenues grow by 17.3% to Euros 3,935 million, and net profit grows by 13.2% reaching Euros 532 million 74
Other Significant Developments 81
Aug 22, 2017: Grifols Phocus Rx Pharmacy Workflow Management Solution Now Integrates With Top Hospital Information Systems via HL7 Interfaces 81
Oct 20, 2016: The CLIA Lab at the Grifols Immunohematology Center Will Now Offer Both Serology and Molecular Tests 82
Jul 05, 2016: Pedigri: the tool that increases the information transparency to the plasma-derived manufactured in Clayton 83
Jun 16, 2016: Grifols confirms that it has voluntarily signed the EFPIA Code of Conduct 84
Mar 03, 2016: Grifols: The company doesn´t have any tax litigation in any country where it operates 85
Appendix 86
Methodology 86
About GlobalData 86
Contact Us 86
Disclaimer 86
Grifols SA, Medical Equipment, Key Facts, 2016 2
Grifols SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Grifols SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Grifols SA, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Grifols SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Grifols SA, Deals By Market, 2011 to YTD 2017 9
Grifols SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Grifols Acquires Nucleic Acid Testing Donor Screening Unit from Hologic for USD1.85 Billion 11
Grifols Acquires Blood Transfusion Diagnostics Business from Novartis for USD1.66 Billion 13
Singulex Enters into Licensing Agreement with Grifols 15
Grifols and Beckman Coulter Enter into Distribution Agreement 16
Grifols Enters Into Distribution Agreement With Kainos Labs 17
Health Robotics Enters Into Co-Marketing Agreement With Grifols 18
Grifols Enters Into Co-Marketing Agreement With Novartis 19
Grifols Enters Into Licensing Agreement With Aradigm 20
Grifols Invests USD50 Million in Singulex 21
TiGenix Completes Private Placement Of Shares For US$16.2 Million 22
Grifols Raises USD1.06 Billion in Public Offering of 3.2% Bonds Due 2025 23
Grifols Completes Public Offering Of Bonds Due 2022 For US$1 Billion 24
Grifols Acquires Additional 40% Stake in Kiro Grifols for USD15 Million 25
Grifols Acquires Additional 32.93% Stake in Progenika Biopharma for USD27 Million 26
Grifols Acquires 50% Stake in Kiro Robotics for USD27 Million 27
Alken Asset Management Sells 2.72% Stake In Grifols For US$227 Million 28
Grifols Completes Acquisition Of 35% Stake In Aradigm For US$26 Million 29
Grifols Acquires 60% Stake In Progenika Biopharma For US$48 Million 30
Grifols Acquires Remaining 51% Stake In Lateral-Medion 31
Grifols SA, Key Competitors 32
Grifols SA, Key Employees 33
Grifols SA, Other Locations 34
Grifols SA, Subsidiaries 34
